Journal profile · ONCOLOGY
Case Reports in Oncological Medicine
ISSN 2090-6706 · eISSN 2090-6714 · John Wiley & Sons, Inc. · USA
Case Reports in Oncological Medicine: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC about USD 870; median 88 days to acceptance (100 articles, last 24 months); acceptance rate 47% (journal website); 73 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
Case Reports in Oncological Medicine is published by John Wiley & Sons, Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Sarcoma Diagnosis and Treatment, Cancer Diagnosis and Treatment and Lymphoma Diagnosis and Treatment, together about 23.4% of its articles. Its main subfields are Pulmonary and Respiratory Medicine and Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Case Reports in Oncological Medicine is an open access journal that publishes case reports and case series related to breast cancer, lung cancer, gastrointestinal cancer, skin cancer, head and neck cancer, paediatric oncology, neurooncology as well as genitourinary cancer.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Sarcoma Diagnosis and TreatmentMedicine10.1%
- Cancer Diagnosis and TreatmentMedicine6.9%
- Lymphoma Diagnosis and TreatmentMedicine6.5%
- Neuroendocrine Tumor Research AdvancesMedicine5.4%
- Cancer and Skin LesionsMedicine5.3%
- Cardiac tumors and thrombiMedicine4.7%
- Cancer Immunotherapy and BiomarkersMedicine4.4%
- Metastasis and carcinoma case studiesMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2023
- 0.6Publisher website ·
- h-index
- 27OpenAlex ·
- i10-index
- 276OpenAlex ·
- 2-year mean citedness
- 0.47OpenAlex ·
- Self-citation rate
- 16.7%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 71LetPub ·
Articles by year OpenAlex count · 987 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 68 | 68 | 9 |
| 2025 | 73 | 73 | 34 |
| 2024 | 31 | 31 | 38 |
| 2023 | 10 | 10 | 20 |
| 2022 | 13 | 13 | 51 |
| 2021 | 29 | 29 | 115 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
88 daysMedian, submission to acceptance · P25–P75 65 days – 150 days
- Acceptance to online
- median 24 days (100 articles)
- Submission to online
- median 127 days
- Sample
- 100 articles with submission and acceptance dates (138 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Acceptance rate (publisher) 2023
- 47%Publisher website ·
- Submission to first decision 2023
- 37 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 870 / GBP 580 / EUR 750 | Yes | CC BY | |
| OpenAlex | USD 790 / EUR 680 / GBP 580 | — | — | |
| LetPub | USD 725 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- case reportCase ReportLength not stated
- case seriesCase SeriesLength not stated
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- John Wiley & Sons, Inc.
- Country or region
- USA
- Language
- English
- ISSN
- 2090-6706
- Electronic ISSN
- 2090-6714
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Case Reports in Oncological Medicine
What CAS zone is Case Reports in Oncological Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Case Reports in Oncological Medicine is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Case Reports in Oncological Medicine?
Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 88 days (interquartile range 65–150 days); authors report an average review time of about 16 weeks; the journal's website gives an acceptance rate of 47% (2023). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Case Reports in Oncological Medicine?
According to LetPub and DOAJ records, Case Reports in Oncological Medicine is indexed in ESCI and DOAJ.
Is Case Reports in Oncological Medicine open access, and what is the APC?
Case Reports in Oncological Medicine is a fully open-access journal. APC about USD 870.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .